A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.
about
The emerging role of FTY720 (Fingolimod) in cancer treatmentQuantification of OSU-2S, a novel derivative of FTY720, in mouse plasma by liquid chromatography-tandem mass spectrometry.Selective targeting of alveolar type II respiratory epithelial cells by anti-surfactant protein-C antibody-conjugated lipoplexesTargeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.Nanoparticulate fingolimod delivery system based on biodegradable poly (3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV): design, optimization, characterization and in-vitro evaluation.Nano- and micro-based systems for immunotolerance induction in multiple sclerosis.Mannan Derivatives Instruct Dendritic Cells to Induce Th1/Th2 Cells Polarization via Differential Mitogen-Activated Protein Kinase Activation.A review of bioanalytical quantitative methods for selected sphingosine 1-phosphate receptor modulators.A novel intracellular pH-responsive formulation for FTY720 based on PEGylated graphene oxide nano-sheets.
P2860
Q26748927-95D50C28-580D-437A-8FB2-6F5C9E48AA3FQ34266856-CFB7F590-BBBD-4EA9-8017-6253686BEE68Q35434883-61D83CB2-9E7F-48F1-A100-E5D3A43F993DQ37129235-A1801910-2D05-4105-8FCC-A77719FCF102Q38418305-D39F48DE-8115-45BE-8A3A-B67DFB7AFCB4Q38546700-62928BAD-02A8-4D6A-90D2-6179727AD798Q38678579-B46BF9A1-921F-4984-A0CC-30040ECA2617Q40336488-0AAE9DC0-1365-4078-877E-1B25EC96BD22Q40786516-64E9AC97-84C4-4044-B58E-4B386315F16DQ41019947-453B2524-E5C3-49E8-9A1C-7478AADC4A57Q47679381-FB1FEB04-1D8D-4E08-B652-5A37D3B17B2FQ49687670-52C01DB0-34D5-414C-B376-7F39FF1C5098
P2860
A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A novel liposomal formulation ...... ng enhanced targeted delivery.
@en
A novel liposomal formulation of FTY720
@nl
type
label
A novel liposomal formulation ...... ng enhanced targeted delivery.
@en
A novel liposomal formulation of FTY720
@nl
prefLabel
A novel liposomal formulation ...... ng enhanced targeted delivery.
@en
A novel liposomal formulation of FTY720
@nl
P2093
P2860
P1476
A novel liposomal formulation ...... ng enhanced targeted delivery.
@en
P2093
Ching-Shih Chen
Jiang Wang
Kwang Joo Kwak
L James Lee
Mitch A Phelps
Natarajan Muthusamy
Robert J Lee
Yicheng Mao
P2860
P304
P356
10.1016/J.NANO.2013.08.001
P50
P577
2013-08-20T00:00:00Z